Filing Details
- Accession Number:
- 0001104659-22-030022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-03 16:19:08
- Reporting Period:
- 2022-03-01
- Accepted Time:
- 2022-03-03 16:19:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1898760 | Margaret Koziel | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-01 | 553 | $1.86 | 26,699 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"), and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.86 to $1.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The Form 3 filed by the reporting person on December 13, 2021 inadvertently overstated the number of securities beneficially owned by 2,748 shares in Table I, Column 2.
- Includes RSUs. Each RSU represents a contingent right to receive one share of AXLA common stock.
Billionaire Hedge Funds
